Is diabetes distress on your radar screen?

,; ,; ,; ,

Applied Evidence

Is diabetes distress on your radar screen?

J Fam Pract. 2017 January;66(1):9-14

PDF Download

References

1. Gafarian CT, Heiby EM, Blair P, et al. The diabetes time management questionnaire. Diabetes Educator. 1999;25:585-592.

2. Wdowik MJ, Kendall PA, Harris MA. College students with diabetes: using focus groups and interviews to determine psychosocial issues and barriers to control. Diabetes Educator. 1997;23:558-562.

3. Rubin RR. Psychological issues and treatment for people with diabetes. J Clin Psych. 2001;57:457-478.

4. Ali MK, Bullard KM, Gregg EW. Achievement of goals in US diabetes care, 1999-2010. New Engl J Med. 2013;369:287-288.

5. Lloyd CE, Smith J, Weinger K. Stress and diabetes: Review of the links. Diabetes Spectrum. 2005;18:121-127.

6. Weinger K. Psychosocial issues and self-care. Am J Nurs. 2007;107(6 suppl): S34-S38.

7. Weinger K, Jacobson AM. Psychosocial and quality of life correlates of glycemic control during intensive treatment of type 1 diabetes. Patient Education Counseling. 2001;42:123-131.

8. Albright TL, Parchman M, Burge SK. Predictors of self-care behavior in adults with type 2 diabetes: an RRNeST study. Fam Med. 2001;33:354-360.

9. Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30:2222-2227.

10. Gonzalez JS, Safren SA, Delahanty LM, et al. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabetic Med. 2008;25:1102-1107.

11. Nicolucci A, Kovacs Burns K, Holt RI, et al. Diabetes Attitudes, Wishes and Needs second study (DAWN2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabetic Med. 2013;30:767-777.

12. Fisher L, Hessler DM, Polonsky W, et al. When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012;35:259-264.

13. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetic Med. 2014;31:764-772.

14. Fisher L, Mullan JT, Skaff MM, et al. Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study. Diabetic Med. 2009;26:622-627.

15. Fisher L, Skaff MM, Mullan JT, et al. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007;30:542-548.

16. Gonzalez JS, Delahanty LM, Safren SA, et al. Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes. Diabetologia. 2008;51:2822-1825.

17. Fisher L, Mullan JT, Arean P, et al. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010;33:23-28.

18. Fisher EB, Thorpe CT, Devellis BM, et al. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educator. 2007;33:1080-1103; 1104-1086.

19. Peterson KA, Radosevich DM, O’Connor PJ, et al. Improving diabetes care in practice: findings from the TRANSLATE trial. Diabetes Care. 2008;31:2238-2243.

20. Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care. 2010;33:1034-1036.

21. Cole J, McGuffin P, Farmer AE. The classification of depression: are we still confused? Br J Psychiatr. 2008;192:83-85.

22. Wakefield JC. The concept of mental disorder. On the boundary between biological facts and social values. Am Psychologist. 1992;47:373-388.

23. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetic Med. 2014;31:764-772.

24. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.

25. Fisher L, Skaff MM, Mullan JT, et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabetic Med. 2008;25:1096-1101.

26. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754-760.

27. McGuire BE, Morrison TG, Hermanns N, et al. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 2010;53:66-69.

28. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28:626-631.

29. Fisher L, Glasgow RE, Mullan JT, et al. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6:246-252.

30. Fisher L, Polonsky WH, Hessler DM, et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications. 2015;29:572-577.

31. Fisher L, Hessler D, Glasgow RE, et al. REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care. 2013;36:2551-2558.

32. Hermanns N, Schmitt A, Gahr A, et al. The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care. 2015;38:551-560.

33. Weinger K, Beverly EA, Smaldone A. Diabetes self-care and the older adult. Western J Nurs Res. 2014;36:1272-1298.

34. Beverly EA, Ritholz MD, Shepherd C, et al. The psychosocial challenges and care of older adults with diabetes: “can’t do what I used to do; can’t be who I once was.” Curr Diabetes Rep. 2016;16:48.

35. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PloS One. 2009;4:e4144.

36. Thabit H, Kyaw TT, McDermott J, et al. Executive function and diabetes mellitus—a stone left unturned? Curr Diabetes Rev. 2012;8:109-115.

37. McNally K, Rohan J, Pendley JS, et al. Executive functioning, treatment adherence, and glycemic control in children with type 1 diabetes. Diabetes Care. 2010;33:1159-1162.

38. Rucker JL, McDowd JM, Kluding PM. Executive function and type 2 diabetes: putting the pieces together. Phys Ther. 2012;92:454-462.

39. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650-2664.

40. Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA. 2006;295:1935-1940.

41. Oftedal B, Karlsen B, Bru E. Life values and self-regulation behaviours among adults with type 2 diabetes. J Clin Nurs. 2010;19:2548-2556.

42. Morrow AS, Haidet P, Skinner J, et al. Integrating diabetes self-management with the health goals of older adults: a qualitative exploration. Patient Education Counseling. 2008;72:418-423.

43. Huang ES, Gorawara-Bhat R, Chin MH. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc. 2005;53:306-311.

44. Beverly EA, Wray LA, LaCoe CL, et al. Listening to older adults’ values and preferences for Type 2 diabetes care: a qualitative study. Diabetes Spectrum. 2014;27:44-49.

45. American Association of Diabetes Educators. Why refer for diabetes education? American Association of Diabetes Educators. Available at: https://www.diabeteseducator.org/practice/provider-resources/why-refer-for-diabetes-education. Accessed August 15, 2016.

46. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363:1589-1597.

Both studies support the use of problem-solving therapy and cognitive behavioral interventions for patients with diabetes distress. Future research should evaluate the effectiveness of these interventions in the primary care setting.

What else to offer when challenges mount?

Diabetes is a progressive disease, and most patients experience multiple challenges over time. These typically include complications and comorbidities, physical limitations, polypharmacy, hypoglycemia, and cognitive impairment, as well as changes in everything from medication and lifestyle to insurance coverage and social support.^33,34 All increase the risk for diabetes distress, as well as related psychiatric conditions.

Eighty-four percent of patients with moderate or high diabetes distress didn’t fulfill the criteria for MDD, but 67% of diabetes patients with MDD also had diabetes distress.

Aging and diabetes are independent risk factors for cognitive impairment, for example, and the presence of both increases this risk.³⁵ What’s more, diabetes alone is associated with poorer executive function,^36-38the higher-level cognitive processes that allow individuals to engage in independent, purposeful, and flexible goal-related behaviors. Both poor cognitive function and impaired executive function interfere with the ability to perform self-care behaviors such as adjusting insulin doses, drawing insulin into a syringe, or dialing an insulin dose with an insulin pen.³⁹ This in turn can lead to frustration and increase the likelihood of moderate to high diabetes distress.

Assessing diabetes distress in patients with cognitive impairment, poor executive functioning, or other psychological limitations is particularly difficult, however, as no diabetes distress measures take such deficits into account. Thus, primary care physicians without expertise in neuropsychology should consider referring patients with such problems to specialists for assessment.

Be alert to socioeconomic changes—in employment, insurance coverage, and living situations—that are not addressed in the screening tools.

The progressive nature of diabetes also highlights the need for primary care physicians to periodically screen for diabetes distress and engage in ongoing discussions about what type of care is best for individual patients, and why. When developing or updating treatment plans and making recommendations, it is crucial to consider the impact the treatment would likely have on the patient’s physical and mental health and to explicitly inquire about and acknowledge his or her values and preferences for care.^40-44